AlzBiomarker
MCI-AD vs MCI-Stable: Aβ42 (CSF)
Meta-analysis Results: Meta-analysis of 20 comparisons, showed that baseline levels of Aβ42 in the cerebrospinal fluid were significantly lower in people with mild cognitive impairment who went on to develop Alzheimer’s dementia compared to levels in those who had not declined at follow-up (effect size = 0.663, p <0.0001).

